Australia Animal Drug Compounding Market Size & Outlook
The animal drug compounding market in Australia is expected to reach a projected revenue of US$ 81.2 million by 2033. A compound annual growth rate of 9.6% is expected of Australia animal drug compounding market from 2026 to 2033.
Revenue, 2025 (US$M)
$38.8
Forecast, 2033 (US$M)
$81.2
CAGR, 2026 - 2033
9.6%
Report Coverage
Australia
Related Markets
Australia animal drug compounding market highlights
- The Australia animal drug compounding market generated a revenue of USD 38.8 million in 2025 and is expected to reach USD 81.2 million by 2033.
- The Australia market is expected to grow at a CAGR of 9.6% from 2026 to 2033.
- In terms of segment, oral was the largest revenue generating route of administration in 2025.
- Topical is the most lucrative route of administration segment registering the fastest growth during the forecast period.
Animal drug compounding market data book summary
| Market revenue in 2025 | USD 38.8 million |
| Market revenue in 2033 | USD 81.2 million |
| Growth rate | 9.6% (CAGR from 2026 to 2033) |
| Largest segment | Oral |
| Fastest growing segment | Topical |
| Historical data | 2021 - 2024 |
| Base year | 2025 |
| Forecast period | 2026 - 2033 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Other Routes, Oral, Topical, Injectable |
| Key market players worldwide | Partners Group Holding AG, Vimian Group AB, Pharmaca, Akina, Triangle Compounding Pharmacy, Central Compounding Pharmacy, Wellness Compounding Pharmacy, Miller Pharmacy |
Other key industry trends
- In terms of revenue, Australia accounted for 2.3% of the global animal drug compounding market in 2025.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2033.
- In Asia Pacific, China animal drug compounding market is projected to lead the regional market in terms of revenue in 2033.
- India is the fastest growing regional market in Asia Pacific and is projected to reach USD 130.6 million by 2033.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Animal Drug Compounding Market Scope
Animal drug compounding market segmentation & scope
Animal Drug Compounding Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Miller Pharmacy | View profile | - | Wyalusing, Pennsylvania, United States, North America | https://www.millerswyalusing.com/ |
| Wellness Compounding Pharmacy | View profile | 1-10 | Cary, North Carolina, United States, North America | https://www.carywellnessrx.com |
| Central Compounding Pharmacy | View profile | 11-50 | Santa Monica, California, United States, North America | https://www.mycentralpharmacy.com |
| Triangle Compounding Pharmacy | View profile | 11-50 | Cary, North Carolina, United States, North America | https://trianglecompounding.com |
| Akina | View profile | 11-50 | Zurich, Zurich, Switzerland, Europe | https://www.akina.health/ |
| Pharmaca | View profile | 501-1000 | Boulder, Colorado, United States, North America | http://www.pharmaca.com |
| Partners Group Holding AG | View profile | 1877 | Zugerstrasse 57, Baar, Zug, Switzerland, 6341 | https://www.partnersgroup.com |
| Vimian Group AB | View profile | 1100 | Riddargatan 19, Stockholm, Sweden, SE-11457 | https://www.vimian.com |
Australia animal drug compounding market size, by route of administration, 2021-2033 (US$M)
Australia Animal Drug Compounding Market Outlook Share, 2025 & 2033 (US$M)
Related industry reports
Related statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
